Evidence map›Paper›PMID 39744166›Full record

ArticleInternational journal of medical sciences2025

Cadherin 23 is a prognostic marker of pancreatic cancer and promotes cell viability in floating culture conditions.

Chaohui Zhen, Peiwei Sun, Rui Liang, Shuang Fei, Xu Chen, Junlin Qian, Baoshi Xu, QiRui Lin, Guojun Yao, Biao Zheng

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of medical sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Chaohui ZhenDepartment of Surgery, The First Dongguan Affiliated Hospital, Guangdong Medical University. Dongguan, Guangdong 523710, China.
Peiwei SunDepartment of General Surgery, Shenzhen University General Hospital/Shenzhen University Clinical Medical Academy, Shenzhen, Guangdong 518055, China.
Rui LiangDepartment of Surgery, The First Dongguan Affiliated Hospital, Guangdong Medical University. Dongguan, Guangdong 523710, China.
Shuang FeiDepartment of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Xu ChenDepartment of Surgery, The First Dongguan Affiliated Hospital, Guangdong Medical University. Dongguan, Guangdong 523710, China.
Junlin QianDepartment of Surgery, The First Dongguan Affiliated Hospital, Guangdong Medical University. Dongguan, Guangdong 523710, China.
Baoshi XuDepartment of Surgery, The First Dongguan Affiliated Hospital, Guangdong Medical University. Dongguan, Guangdong 523710, China.
QiRui LinDepartment of Clinical Application, Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, Japan.
Guojun YaoDepartment of Geriatrics, The First Affiliated Hospital of Shenzhen University, Shenzhen Second People's Hospital, Shenzhen, Guangdong 518000, China.
Biao ZhengDepartment of Surgery, The First Dongguan Affiliated Hospital, Guangdong Medical University. Dongguan, Guangdong 523710, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Biomarkers, TumorCadherinsCell SurvivalPancreatic NeoplasmsAgedCadherin Related ProteinsCell Line, TumorCell MovementFemaleGene Expression Regulation, NeoplasticHumansMaleMiddle AgedPrognosisBiomarkers, TumorCadherin Related ProteinsCadherinsCDH23 protein, humanCadherin 23Pancreatic neoplasmsPrognostic markerTumor microenvironment

Identifiers

PMID39744166
PMCPMC11659824

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.